ClinicalTrials.gov
ClinicalTrials.gov Menu

Fractional Nonablative 1540 nm Laser Resurfacing for Burn Scars- A Randomised Controlled Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00689650
Recruitment Status : Unknown
Verified May 2008 by Bispebjerg Hospital.
Recruitment status was:  Active, not recruiting
First Posted : June 3, 2008
Last Update Posted : June 3, 2008
Sponsor:
Information provided by:
Bispebjerg Hospital

Brief Summary:
The objective was to evaluate the efficacy of 1540 nm fractional laser treatment of mature burn scars.

Condition or disease Intervention/treatment Phase
Burn Scar Patients Device: 1540 nm fractional laser Not Applicable

Study Type : Interventional  (Clinical Trial)
Official Title: Fractional Nonablative 1540 nm Laser Resurfacing for Burn Scars- A Randomised Controlled Trial
Study Start Date : November 2007

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Burns Scars

Arm Intervention/treatment
Experimental: A Device: 1540 nm fractional laser
No Intervention: B



Primary Outcome Measures :
  1. Change of skin texture from baseline


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Burn scars with and without previous skin grafting.

Exclusion Criteria:

  • A tendency to produce hypertrophic scars or keloids,
  • Previous treatment with dermabrasio, chemical peel, filler, laser treatment or Intense Pulsed Light (IPL) of study areas,
  • Photosensitivity,
  • Pregnancy or lactation,
  • Current anticoagulative medication,
  • Oral retinoid drugs within the past 6 months,
  • Pigmentation after recent exposure to sun or solarium,
  • Patients not considered to be able to follow the treatment protocol.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00689650


Locations
Denmark
Bispebjerg University Hospital
Copenhagen NV, Denmark, 2400
Sponsors and Collaborators
Bispebjerg Hospital

ClinicalTrials.gov Identifier: NCT00689650     History of Changes
Other Study ID Numbers: H-D-2007-0094
First Posted: June 3, 2008    Key Record Dates
Last Update Posted: June 3, 2008
Last Verified: May 2008

Additional relevant MeSH terms:
Burns
Cicatrix
Wounds and Injuries
Fibrosis
Pathologic Processes